CHRYSALIS BIOTHERAPEUTICS, INC. (TX)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2011
- $21.68M
- $21,684,476under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 4
- with positive net obligations
- Latest action
- Jul 25, 2025
- SAM.gov registration
- Active
- Registration expiration date Aug 6, 2027
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Mar 13, 2009 (17 years)
- Location
- Galveston, TX
- State of incorporation
- Delaware
- Purpose of registration
- All Awards
- Website
- chrysbio.com
† FY2026 obligations (provisional; DoD awards signed after Jul 26, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI XW1VFGGRLDW3. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2011. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2025: -$11,857,903 (de-obligation)
- FY2023: -$0 (de-obligation)
- FY2022: $3,000,000
- FY2021: $10,455,381
- FY2020: $2,858,907
- FY2019: $11,938,991
- FY2018: $1,984,041
- FY2017: $1,605,375
Show all 10 yearsEarlier years (FY2011–FY2013)
- FY2013: $1,499,927
- FY2011: $199,757
Total across 10 fiscal years: $21,684,476
Net de-obligation in that fiscal year (obligations withdrawn).
Top awarding agencies
- Department of Health and Human Services$21,684,476, 100%
Top awarding sub-agencies
- Office of Assistant Secretary for Preparedness and Response$13,030,326, 60.1%
- National Institutes of Health$8,654,150, 39.9%
Top NAICS by obligations
- 541711Research and development in biotechnology$8,654,150, 39.9%
Top product and service codes by obligations
- AN13R&d- medical: biomedical (advanced development)$13,030,326, 60.1%
- AN11R&d- medical: biomedical (basic research)$8,654,150, 39.9%
Capabilities
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)(primary)Small
- 325412Pharmaceutical Preparation ManufacturingSmall
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Product and service codes (PSC)
- AJ12General Science and Technology R&D Services; General science and technology; Applied Research
Federal Capability Statement
Therapeutic Drug Development
Capabilities & Services
Contracts
Latest awards and orders
- 75A50119C00016Definitive contractDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseLatest action
- HHSN272201700011CDefinitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
- HHSN261201300076CDefinitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
- HHSN261201100035CDefinitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for CHRYSALIS BIOTHERAPEUTICS, INC. lists a physical address and a separate mailing address, along with 6 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
1700 Strand St Suite 2.302
Galveston, TX, 77550
USA
Mailing Address
1125 Tallow Drive
Dickinson, TX, 77539
USA
Government Business Contact
DARRELL H Carney
President and CEO
Chrysalis BioTherapeutics Inc
1700 Strand ST, STE 2.302
Galveston, TX, 77550
USA
Electronic Business Contact
DARRELL H Carney
President and CEO
Chrysalis BioTherapeutics Inc
1700 Strand ST, STE 2.302
Galveston, TX, 77550
USA
Past Performance Contact
DARRELL H Carney
President and CEO
Chrysalis BioTherapeutics Inc
1700 Strand ST, STE 2.302
Galveston, TX, 77550
USA
Government Business Alternate Contact
Laurie E Sower
EVP
Chrysalis BioTherapeutics Inc
1700 Strand ST, STE 2.302
Galveston, TX, 77550
USA
Electronic Business Alternate Contact
DARRELL H Carney
President and CEO
1125 TALLOW DRIVE
DICKINSON, TX, 77539
USA
Past Performance Alternate Contact
Laurie E Sower
Executive VP
Chrysalis BioTherapeutics Inc
1700 Strand ST, STE 2.302
Galveston, TX, 77550
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
CHRYSALIS BIOTHERAPEUTICS, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires August 6, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in Texas with primary NAICS 541714
- Nanohmics IncAustin, TX
- Heliowave Technologies IncCollege Station, TX
- Memsel Inc.Fort Worth, TX
- Rhodium Scientific LLCHouston, TX
- Sentinel Environmental Group LLCHouston, TX
- Iprocess Global Research Inc.Irving, TX